GenScript launches a series of beta amyloid peptides geared toward Alzheimer’s disease research

PRLog (Press Release) - Dec 12, 2008 -
Summary: GenScript backs up beta amyloid peptide resources for AD research.

PISCATAWAY, N.J.,  -International contract research organization (CRO) GenScript Corporation has launched a series of beta amyloid peptide fragments targeting Alzheimer’s disease (AD).

This series of peptide products cover both human and rat beta amyloid peptide fragments, selected for research value, particularly their relevance to AD. These peptide fragments cause different biological responses either alone or in combination. GenScript representatives claim that these synthetic beta amyloid peptides will assist scientists in elucidating the specific roles of beta amyloid peptides in AD’s pathogenic process, possibly helping the development of effective interventions for AD.

The peptides are generated through GenScript's FlexPeptide™ peptide synthesis platform based solely on each fragment’s amino acid sequence information. The platform is equipped with automated synthesizers and covers both liquid and solid phase peptide synthesis (SPPS and LPPS), microwave technology, and proprietary ligation technologies. FlexPeptide™ is also key to GenScript's custom, GMP, and cosmetic peptide production services.

FlexPeptide™'s generalized production protocol requires only the amino acid sequence, giving GenScript a potential to expand its selection of beta amyloid peptides. In addition, GenScript plans to offer modified beta amyloid peptides soon. For now, GenScript also offers a set of neurological antibodies targeting AD research.

GenScript Corporation is a reliable outsourcing partner providing a wide array of services to augment all stages of the drug discovery and biological reagent manufacturing processes, including high-quality gene synthesis and cloning, custom protein expression and purification, custom peptide synthesis and antibody development, custom stable cell line development, and a wide selection of biological reagents to life science researchers in industrial and academic settings. GenScript Corporation is headquartered in Piscataway, New Jersey.


#  #  #


Source: http://www.genscript.com/beta_amyloid_peptide.html

GenScript Corporation
120 Centennial Ave.
Piscataway, NJ
08854
U.S.

Your one-stop web lab for biology!

© 2008 GENSCRIPT CORP.  All rights reserved. FlexPeptideTM is a registered trademark of GenScript Corporation.